Hu J - Search Results

1

Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification.

Wang H, Li L, Ye J, Dong W, Zhang X, Xu Y, Hu J, Wang R, Xia X, Yang Y, Jin D, Wang R, Song Z, Gao L, Liu Y. Wang H, et al. Among authors: hu j. Molecules. 2021 Jan 18;26(2):484. doi: 10.3390/molecules26020484. Molecules. 2021. PMID: 33477555 Free PMC article.

2

CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.

Chen J, Lv H, Hu J, Ji M, Xue N, Li C, Ma S, Zhou Q, Lin B, Li Y, Yu S, Chen X. Chen J, et al. Among authors: hu j. Cancer Lett. 2016 Oct 28;381(2):391-403. doi: 10.1016/j.canlet.2016.07.030. Epub 2016 Aug 2. Cancer Lett. 2016. PMID: 27495899

3

Simultaneous determination of a promising anti-brain tumor agent CAT3 and its two major metabolites in mouse plasma and brain by a LC-MS/MS method.

Zhao S, Wang RB, Bai J, Fan X, Hu M, Wang B, Hu J, Li Y. Zhao S, et al. Among authors: hu j, hu m. J Pharm Biomed Anal. 2020 Mar 20;181:113106. doi: 10.1016/j.jpba.2020.113106. Epub 2020 Jan 9. J Pharm Biomed Anal. 2020. PMID: 31962248

4

Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates.

Wang H, Li L, Ye J, Wang R, Wang R, Hu J, Wang Y, Dong W, Xia X, Yang Y, Gao Y, Gao L, Liu Y. Wang H, et al. Among authors: hu j. Pharmaceutics. 2020 Feb 3;12(2):126. doi: 10.3390/pharmaceutics12020126. Pharmaceutics. 2020. PMID: 32028734 Free PMC article.

5

Pharmacokinetics and tissue distribution of Ramulus Mori (Sangzhi) alkaloids in rats and its effects on liver enzyme activity.

Liu Z, Feng Y, Zhao H, Hu J, Chen Y, Liu D, Wang H, Zhu X, Yang H, Shen Z, Xia X, Ye J, Liu Y. Liu Z, et al. Among authors: hu j. Front Pharmacol. 2023 Feb 17;14:1136772. doi: 10.3389/fphar.2023.1136772. eCollection 2023. Front Pharmacol. 2023. PMID: 36873997 Free PMC article.

6

[Effect of CYP3A and P-glycoprotein on the absorption of buagafuran in rat intestinal lumen].

Sheng L, Tan W, Hu JP, Chen H, Li Y. Sheng L, et al. Yao Xue Xue Bao. 2010 Jan;45(1):43-8. Yao Xue Xue Bao. 2010. PMID: 21351448 Chinese.

7

Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor.

Huang K, Hu J, Li X, Li Y. Huang K, et al. Among authors: hu j. Drug Metab Pharmacokinet. 2012;27(5):486-94. doi: 10.2133/dmpk.dmpk-11-rg-142. Epub 2012 Mar 22. Drug Metab Pharmacokinet. 2012. PMID: 22447116 Free article.

8

The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.

You F, Hu J, Li X, Li Y. You F, et al. Among authors: hu j. Cancer Chemother Pharmacol. 2013 Jun;71(6):1453-62. doi: 10.1007/s00280-013-2144-7. Epub 2013 Apr 5. Cancer Chemother Pharmacol. 2013. PMID: 23558944

9

Application of physiologically based pharmacokinetic modeling in the prediction of pharmacokinetics of bicyclol controlled-release formulation in human.

Wang B, Liu Z, Li D, Yang S, Hu J, Chen H, Sheng L, Li Y. Wang B, et al. Among authors: hu j. Eur J Pharm Sci. 2015 Sep 18;77:265-72. doi: 10.1016/j.ejps.2015.06.020. Epub 2015 Jun 24. Eur J Pharm Sci. 2015. PMID: 26116279

10

A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.

Wang YD, Bao XQ, Xu S, Yu WW, Cao SN, Hu JP, Li Y, Wang XL, Zhang D, Yu SS. Wang YD, et al. J Med Chem. 2016 Oct 13;59(19):9062-9079. doi: 10.1021/acs.jmedchem.6b00976. Epub 2016 Sep 27. J Med Chem. 2016. PMID: 27617803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,660 results

Search Page

Filters